Molecular glues can shield insulin-producing cells from diabetes-related damage

Researchers from the Icahn School of Medicine at Mount Sinai in New York have discovered a novel approach to protecting insulin-producing beta cells from the damaging effects of glucolipotoxicity—a harmful condition linked to the progression of type 2 diabetes (T2D). These findings, published on March 2, 2025 in Nature Communications, could lead to promising treatments targeting beta cell dysfunction.

Out-of-balance gut bacteria are linked to multiple sclerosis—the ratio can predict severity of disease

Multiple sclerosis is a disease that results when the immune system mistakenly attacks the brain and spinal cord. It affects nearly 1 million people in the U.S. and over 2.8 million worldwide. While genetics play a role in the risk of developing multiple sclerosis, environmental factors such as diet, infectious disease and gut health are major contributors.

Police study shows why some are more susceptible to developing PTSD symptoms than others

People with a more active amygdala (an area in the brain involved in processing information relevant to threats) are more likely to develop PTSD symptoms after experiencing trauma than people with a calmer amygdala. This is evident from research on police officers by neuroscientist Linda de Voogd together with a team of scientists led by Karin Roelofs of Radboud University.